Sensome
From Bio-Impedance to Clinical Insights
Massy · Founded 2014 · $27.6M raised
- Headquarters
- Massy
- Founded
- 2014
- Business Model
- B2B
- Website
- sensome.com
- Total Funding
- $27.6M
- Last Round
- $7.9M Series CJul 2024
- Rounds
- 4
About
Sensome develops tissue-sensing microchip technology that gives physicians real-time, patient-specific tissue information during minimally invasive medical procedures. Its lead product, the Clotild Smart Guidewire System, manufactured with Asahi Intecc, is a tissue-sensing neurovascular guidewire pursuing regulatory clearance in the EU, US, and Japan for treating acute ischemic stroke. The bio-impedance sensing platform has also shown clinical feasibility in lung cancer biopsy guidance and peripheral vascular intervention; the company was formerly known as Insent.
Summary
Sensome is a Biotech company based in Massy, founded in 2014. It has raised $27.6M in total across 4 rounds, most recently a $7.9M Series C round in Jul 2024.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...